← FDA Drug Approvals (Drugs@FDA)

PEMETREXED DISODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2023-03-10

Drug application

FDA Application #

ANDA203628

Application type

Abbreviated New Drug Application (Generic)

Brand name

PEMETREXED DISODIUM

Generic name

Pemetrexed Disodium

Active ingredients

PEMETREXED DISODIUM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

2023-03-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown